We report multi-site nucleation and growth of Ag islands on colloidal Au nanoparticles. By modifying a single factor, a range of products from Janus nanoparticles to satellite nanostructures are obtained. The identification of these key factors reveals the correlation between the concentration gradient and the choice of nucleation sites. In contrast to the inhibited homogeneous nucleation in the bulk solution, we argue that the non-steady-state concentration gradient plays a critical role in inhibiting nucleation within nanometer distance during the initial stage of growth-an essential but not yet recognized factor in colloidal synthesis. A depletion sphere model was developed, so that the multi-site nucleation is well integrated with the classic theory of nucleation and growth. Alternative explanations are carefully examined and ruled out. We believe that the synthetic know-how and the mechanistic insights can be broadly applied and are of importance to the advance of nanosynthesis.

BACKGROUND: The process of bone healing is complex and involves the participation of osteogenic stem cells, extracellular matrix, and angiogenesis. The advancement of bone regeneration materials provides a promising opportunity to tackle bone defects. This study introduces a composite hydrogel that can be injected and cured using UV light. RESULTS: Hydrogels comprise bioactive glass (BG) and PCL@GelMA coaxial nanofibers. The addition of BG and PCL@GelMA coaxial nanofibers improves the hydrogels mechanical capabilities (353.22 ± 36.13 kPa) and stability while decreasing its swelling (258.78 ± 17.56%) and hydration (72.07 ± 1.44%) characteristics. This hydrogel composite demonstrates exceptional biocompatibility and angiogenesis, enhances osteogenic development in bone marrow mesenchymal stem cells (BMSCs), and dramatically increases the expression of critical osteogenic markers such as ALP, RUNX2, and OPN. The composite hydrogel significantly improves bone regeneration (25.08 ± 1.08%) in non-healing calvaria defects and promotes the increased expression of both osteogenic marker (OPN) and angiogenic marker (CD31) in vivo. The expression of OPN and CD31 in the composite hydrogel was up to 5 and 1.87 times higher than that of the control group at 12 weeks. CONCLUSION: We successfully prepared a novel injectable composite hydrogel, and the design of the composite hydrogels shows significant potential for enhancing biocompatibility, angiogenesis, and improving osteogenic and angiogenic marker expression, and has a beneficial effect on producing an optimal microenvironment that promotes bone repair.